Publication | Closed Access

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

MedicineEgfr InhibitorsEpithelial-mesenchymal InteractionsBronchial NeoplasmCancer BiologyRadiation OncologyOncologyCell BiologyLung CancerTumor Biology